Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder

NCT06283498 is registered in ClinicalTrials.gov with InMode MD Ltd. as lead sponsor.

NCT NCT06283498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06283498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder
Lead sponsor
InMode MD Ltd.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 10, 2023
Completion date
November 10, 2027
Enrollment
32 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder syndrome